Catalent
CTLT
#1737
Rank
ยฃ8.64 B
Marketcap
ยฃ47.65
Share price
0.00%
Change (1 day)
8.98%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total assets

Total assets on the balance sheet as of September 2024 : ยฃ7.28 Billion

According to Catalent's latest financial reports the company's total assets are ยฃ7.28 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Catalent - Total assets on balance sheet (from 2013 to 2024)

Total assets by year

Year Total assets Change
2023-06-30ยฃ8.47 B-1.89%
2022-06-30ยฃ8.64 B31.14%
2021-06-30ยฃ6.58 B4.97%
2020-06-30ยฃ6.27 B28.86%
2019-06-30ยฃ4.87 B42.01%
2018-06-30ยฃ3.43 B29.17%
2017-06-30ยฃ2.65 B14.51%
2016-06-30ยฃ2.31 B15.92%
2015-06-30ยฃ2.00 B10.77%
2014-06-30ยฃ1.80 B-6.9%
2013-06-30ยฃ1.93 B-3.05%
2012-06-30ยฃ2.00 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Supernus Pharmaceuticals
SUPN
ยฃ1.06 B-85.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
ยฃ0.28 B-96.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
ยฃ8.52 B 16.98%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
ยฃ0.29 B-95.95%๐Ÿ‡บ๐Ÿ‡ธ USA